The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Pigment epithelium‐derived factor (PEDF) is an endogenous antiinflammatory factor
Abstract
Pigment epithelium‐derived factor (PEDF) is a potent angiogenic inhibitor. Reduced PEDF levels are associated with diabetic retinopathy. However, the mechanism for the protective effects of PEDF against diabetic retinopathy (DR) is presently unclear. As inflammation plays a role in DR, the present study determined the effect of PEDF on inflammation. Western blot analysis and ELISA demonstrated that retinal and plasma PEDF levels were drastically decreased in rats with endotoxin‐induced uveitis (EIU), which suggests that PEDF is a negative acute‐phase protein. Intravitreal injection of PEDF significantly reduced vascular hyper‐permeability in rat models of diabetes and oxygen‐induced retinopathy, correlating with the decreased levels of retinal inflammatory factors, including VEGF, VEGF receptor‐2, MCP‐1, TNF‐α, and ICAM‐1. In cultured retinal capillary endothelial cells, PEDF significantly decreased TNF‐α and ICAM‐1 expression under hypoxia. Moreover, down‐regulation of PEDF expression by siRNA resulted in significantly increases of VEGF and TNF‐α secretion in retinal Müller cells. These findings suggest that PEDF is a novel endogenous anti‐inflammatory factor in the eye. The decrease of ocular PEDF levels may contribute to inflammation and vascular leakage in DR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,365
A central role for inflammation in the pathogenesis of diabetic retinopathy
Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1476fje · Cited by 1,176
Liu, Y., Cox, S. R., Morita, T., & Kourembanas, S. (1995) · Circulation Research · doi:10.1161/01.res.77.3.638 · Cited by 1,040
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34102-1 · Cited by 981
Aiello, L. P., Bursell, S.-E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1473 · Cited by 665
PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity
Tombran-Tink, J., Chader, G. G., & Johnson, L. V. (1991) · Experimental Eye Research · doi:10.1016/0014-4835(91)90248-d · Cited by 574
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567
Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina
Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S.-E., & Adamis, A. P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63952-1 · Cited by 567
Endotoxin-induced uveitis in rats as a model for human disease
Rosenbaum, J. T., McDevitt, H. O., Guss, R. B., & Egbert, P. R. (1980) · Nature · doi:10.1038/286611a0 · Cited by 554
VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum, T., Xu, Q., Joussen, A. M., Clemens, M. W., Qin, W., Miyamoto, K., Hasséssian, H., Wiegand, S. J., Rudge, J. S., Yancopoulos, G. D., et al. (2001) · PubMed · Cited by 508
The role of vascular endothelial growth factor in pathological angiogenesis
Ferrara, N. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666035 · Cited by 414
Joussen, A. M., Poulaki, V., Qin, W., Kirchhof, B., Mitsiades, N., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64869-9 · Cited by 392
VEGF164Is Proinflammatory in the Diabetic Retina
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Ahmed, E., Carrasquillo, K. G., Amano, S., Hida, T., Oguchi, Y., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0807 · Cited by 383
PEDF: a multifaceted neurotrophic factor
Tombran-Tink, J., & Barnstable, C. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1176 · Cited by 367
Stellmach, V., Crawford, S. E., Zhou, W., & Bouck, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031252398 · Cited by 355
Funatsu, H., Yamashita, H., Ikeda, T., Mimura, T., Eguchi, S., & Hori, S. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00568-2 · Cited by 346
Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization
Mori, K., Duh, E., Gehlbach, P., Ando, A., Takahashi, K., Pearlman, J., Mori, K., Yang, H. S., Zack, D. J., Ettyreddy, D., et al. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1114 · Cited by 337
Miyamoto, K., Khosrof, S., Bursell, S.-E., Moromizato, Y., Aiello, L. P., Ogura, Y., & Adamis, A. P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65044-4 · Cited by 332
Unbalanced expression of VEGF and PEDF in ischemia‐induced retinal neovascularization
Gao, G., Li, Y., Zhang, D., Gee, S., Crosson, C., & Ma, J.-X. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02110-x · Cited by 297
Self-citationRole of vascular endothelial growth factor in diabetic vascular complications
Aiello, L. P., & Wong, J.-S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07718.x · Cited by 293
VEGF increases retinal vascular ICAM-1 expression in vivo.
Lu, M., Perez, V. L., Ma, N., Miyamoto, K., Peng, H., Liao, J. K., & Adamis, A. P. (1999) · PubMed · Cited by 239
Ogata, N., Nishikawa, M., Nishimura, T., Mitsuma, Y., & Matsumura, M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01568-4 · Cited by 234
Funatsu, H., Yamashita, H., Ikeda, T., Nakanishi, Y., Kitano, S., & Hori, S. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01323-5 · Cited by 169
Koizumi, K., Poulaki, V., Doehmen, S., Welsandt, G., Radetzky, S., Lappas, A., Kociok, N., Kirchhof, B., & Joussen, A. M. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0589 · Cited by 160
The Wisconsin Epidemiologic Study of Diabetic Retinopathy-Reply
Klein, R. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100060024016 · Cited by 155
Clausen, P., Jacobsen, P. K., Rossing, K., Jensen, J. S., Parving, H. ‐., & Feldt‐Rasmussen, B. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00347.x · Cited by 150
Duh, E. J., Yang, H. S., Haller, J. A., de Juan, E., Humayun, M. S., Gehlbach, P. L., Melia, M., Pieramici, D. J., Harlan, J. B., Campochiaro, P. A., et al. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.015 · Cited by 146
Boehm, B. O., Lang, G. K., Volpert, O. V., Jehle, P. M., Kurkhaus, A., Rosinger, S., Lang, G. K., & Bouck, N. (2003) · Diabetologia · doi:10.1007/s00125-003-1040-9 · Cited by 141
Ogata, N., Tombran‐Tink, J., Nishikawa, M., Nishimura, T., Mitsuma, Y., Sakamoto, T., & Matsumura, M. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01008-x · Cited by 136
Diabetic macular edema, Risk factors and concomitants
de Faria, J. M. L., Jalkh, A. E., Trempe, C. L., et al. (1999) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.1999.770211.x · Cited by 133
Gao, G., Li, Y., Gee, S., Dudley, A. C., Fant, J., Crosson, C. E., & Ma, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108004200 · Cited by 132
Self-citationPhotocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group
Ferris, F. L. (1991) · JAMA · doi:10.1001/jama.266.9.1263 · Cited by 129
Liu, H., Ren, J.-G., Cooper, W. L., Hawkins, C. E., Cowan, M., & Tong, P. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308342101 · Cited by 128
Jin, J., Guan, M., Sima, J., Gao, G., Zhang, M., Liu, Z., Fant, J., & Ma, J. (2003) · Cornea · doi:10.1097/00003226-200307000-00015 · Cited by 120
Self-citationMiyahara, S., Kiryu, J., Yamashiro, K., Miyamoto, K., Hirose, F., Tamura, H., Katsuta, H., Nishijima, K., Tsujikawa, A., & Honda, Y. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63728-5 · Cited by 103
MCP-1 expression in endotoxin-induced uveitis.
Tuaillon, N., Shen, D. F., Berger, R. B., Lu, B., Rollins, B. J., & Chan, C. (2002) · PubMed · Cited by 97
Zhang, S. X., Ma, J., Sima, J., Chen, Y., Hu, M. S., Ottlecz, A., & Lambrou, G. N. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62255-9 · Cited by 97
Self-citationGao, G., Li, Y., Fant, J., Crosson, C. E., Becerra, S. P., & Ma, J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1218 · Cited by 94
Self-citationMonocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy
Mitamura, Y., Takeuchi, S., Matsuda, A., Tagawa, Y., Mizue, Y., & Nishihira, J. (2001) · Ophthalmologica · doi:10.1159/000050900 · Cited by 90
Becker, M. D., Garman, K. L., Whitcup, S. M., Planck, S. R., & Rosenbaum, J. T. (2001) · PubMed · Cited by 73
Cousins, S. W., Guss, R. B., Howes, E. L., & Rosenbaum, J. T. (1984) · Experimental Eye Research · doi:10.1016/0014-4835(84)90065-4 · Cited by 70
Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage
Gao, G., Shao*, C., Zhang, S. X., Dudley, A. C., Fant, J., & Ma, J.-X. (2003) · Diabetologia · doi:10.1007/s00125-003-1085-9 · Cited by 65
Self-citationDiabetic macular edema: review and update
Pelzek, C. D., & Lim, J. I. (2002) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(02)00043-3 · Cited by 56
Rohrer, B., & Stell, W. K. (1995) · Brain Research · doi:10.1016/0006-8993(95)00700-z · Cited by 55
Miyamoto, K., Ogura, Y., Hamada, M., Nishiwaki, H., Hiroshiba, N., Tsujikawa, A., Mandai, M., Suzuma, K., Tojo, S. J., & Honda, Y. (1998) · Microvascular Research · doi:10.1006/mvre.1998.2084 · Cited by 27
Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer
Nan, Y., Feng, G., Hotta, Y., Nishiwaki, K., Shimada, Y., Ishikawa, A., 栗本, 奈., Shigei, T., & Ishikawa, N. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00630.2003 · Cited by 17
Cited by
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
The Pathologic Continuum of Diabetic Vascular Disease
Orasanu, G., & Plutzky, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.055 · Cited by 487
Metadata
- Authors
- Zhang, S. X., Wang, J. J., Gao, G., Shao, C., Mott, R., & Ma, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-12-20
- Volume
- 20
- Issue
- 2
- Pages
- 323-325
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2112215733
- Cited by
- 299
- References
- 48
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.